Foster Dykema Cabot & Partners, LLC Boston Scientific Corp Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.19 Trillion
- Q3 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 519 shares of BSX stock, worth $46,071. This represents 0.0% of its overall portfolio holdings.
Number of Shares
519Holding current value
$46,071% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BSX
# of Institutions
1,513Shares Held
1.19BCall Options Held
8.25MPut Options Held
8.72M-
Vanguard Group Inc Valley Forge, PA131MShares$11.7 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$11.2 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$5.58 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.36 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$2.91 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $127B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...